E Fund Management (HK)’s Praxis Precision Medicines PRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.6K Sell
57
-9
-14% -$2.98K ﹤0.01% 442
2026
Q2
$22.1K Buy
66
+20
+43% +$6.33K 0.01% 297
2026
Q1
$14.8K Buy
+46
New +$14.2K 0.01% 258

Other funds holding PRAX

E Fund Management (HK)'s PRAX Position: Q3 2026 in Review

E Fund Management (HK) reduced its Praxis Precision Medicines (PRAX) stake by 14% in Q3 2026, selling an estimated $2.98K and leaving 57 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #442.

E Fund Management (HK) first reported a position in PRAX in Q1 2026 and has held it in 3 quarters since. The position peaked at $22.1K in Q2 2026. 339 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • E Fund Management (HK) held 57 shares of Praxis Precision Medicines worth $16.6K as of Q3 2026.
  • E Fund Management (HK) sold 9 Praxis Precision Medicines shares in Q3 2026, an estimated $2.98K.
  • Praxis Precision Medicines made up ﹤0.01% of E Fund Management (HK)'s portfolio in Q3 2026, its #442 holding.
  • E Fund Management (HK) first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 3 quarters since.
  • E Fund Management (HK)'s Praxis Precision Medicines position peaked at $22.1K in Q2 2026.
  • 339 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on E Fund Management (HK)'s 13F filing for Q3 2026, filed 12 Nov 2026.